Welcome¬†to the EMI
At the University of Cambridge, we offer an exciting new scheme that provides high-quality training in the design and execution of Experimental Medicine studies, equipping clinicians and non-clinician scientists with the knowledge and skills to lead Experimental Medicine studies in the future. The Experimental Medicine¬ Initiative (EMI), recently launched in May 2016, is a strategic scheme, supported by the University of Cambridge in partnership with the Cambridge University Hospitals, NIHR Cambridge Biomedical Research Centre and Industry Partners AstraZeneca/MedImmune and GSK.
The development of new drugs and innovative therapies increasingly relies on Experimental Medicine studies in humans, such as obtaining early proof-of-concept, understanding (patho-) physiology, biomarker development/validation, and evaluating techniques for subject stratification. In order to support the current lack of individuals trained to design and deliver such studies, we have established this Training Initiative which involves partnerships between academia and pharmaceutical companies to address the translational research gap.
This website describes the scheme, its requirements and objectives. It contains information about the Expression of Interest calls, supporting and collaborative partners, recruitment, training days, current students, projects and events as well as career paths typically followed in this field.